J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain-Barré syndrome

Reuters

Center

High Factuality

Private Equity: The Woodbridge Company

U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports

- Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the benefits of its use outweigh the risks, a U.S. Centers for Disease Control and Prevention advisory panel said on Thursday. The U.S. Food and Drug Administration last week added a warning to its fact sheet for J&J's single-shot vaccine saying that data